Fred Alger Management, LLC Sangamo Therapeutics, Inc Transaction History

Fred Alger Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $151,500 - $265,500	-30,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $240,899 - $351,000	30,000 New	30,000 $251,000
Q1 2019 May 14, 2019	SELL	$7.72 - $12.81 $386,000 - $640,500	-50,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $9,510 - $16,600	-1,000 Reduced 1.96%	50,000 $574,000
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $143,550 - $209,550	11,000 Added 27.5%	51,000 $864,000
Q2 2018 Jul 19, 2018	BUY	$13.9 - $19.8 $97,300 - $138,600	7,000 Added 21.21%	40,000 $568,000
Q1 2018 May 10, 2018	BUY	$16.7 - $26.35 $400,800 - $632,400	24,000 Added 266.67%	33,000 $627,000
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $104,400 - $156,150	9,000	9,000 $148,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $294M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.